Bookmarks
Posted on by admin
Posted on by admin
Business Wire - FDA Approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for Type 2 Diabetes, Offering the Powerful Efficacy of JANUMET® (sitagliptin/metformin HCl) Now Available with Once-Daily Convenience
February 2, 2012 --
JANUMET XR can help many patients reach blood sugar goals
WHITEHOUSE STATION, N.J. --...
Business Wire - Microscopic Sponge-Type Particles Zap Nosebleeds, Research at ISET 2012 Shows
January 15, 2012 --
MIAMI BEACH, Fla. -- Nonstop nosebleeds can be serious and frightening, often sending people to the emergency room where their...
Evening Chronicle (Newcastle, England) - Disease hits kids
January 14, 2012 --
ACUTE lymphoblastic leukaemia (ALL) is the most common type of leukaemia in children, with around 380 cases diagnosed each year in...
Business Wire - Prevention Study with Diamyd's Diabetes Vaccine Fully Recruited
January 9, 2012 --
STOCKHOLM, Sweden -- Regulatory News:
A total of 50 children aged four and older with a high risk of ...
Business Wire - Allos Therapeutics Requests Re-Examination of CHMP Opinion on FOLOTYN® in PTCL at the European Medicines Agency
January 1, 2012 --
WESTMINSTER, Colo. -- Allos Therapeutics, Inc. (NASDAQ: ALTH) today announced that it has submitted a request to the European...
Medical Laboratory Observer - Stewardship of the bloodline: driving safety and efficiency along the transfusion continuum
January 1, 2012 --
The demand for providing safe, compatible blood at an ever-increasing pace is growing in hospitals and other healthcare facilities around the...
Market Wire - Show Us Your Moves
January 1, 2012 --
Physical activity is one of the best methods of improving blood glucose, as well as blood pressure and cholesterol. The February issue of...
Townsend Letter - Laboratory testing
January 1, 2012 --
In medicine, standardized laboratory tests, performed by machine, take a very complicated biological system that is constantly striving for...
Market Wire - DiaMedica's DM-204 for Type 2 Diabetes Significantly Lowers Blood Glucose, Blood Pressure and Cholesterol Levels
December 1, 2011 --
DiaMedica Inc. (TSX VENTURE:DMA) is pleased to announce the presentation of new compelling Type 2 diabetes data from studies of DM-204 at the...
Nordic Business Report - -Danish Novo Nordisk discloses positive data on insulin analogues
December 1, 2011 --
NORDIC BUSINESS REPORT-December 5, 2011--Danish Novo Nordisk discloses positive data on insulin analogues(C)2011 M2 COMMUNICATIONS...